WIPO trademark

Isomorphic Labs

MixedWIPOClass 5Class 9Class 42

"Isomorphic Labs" is a trademark owned by Isomorphic Labs Limited, filed at the WIPO on September 22, 2025. It is on file and covers classes 5, 9 and 42.

Isomorphic Labs
Trademark as filed with the WIPO
Status
Mixed
Filed
September 22, 2025
Registered
Not yet
Expires
September 22, 2035
Application no.
Not recorded
Registration no.
1895081
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
3 classes
Ownership

Who owns Isomorphic Labs

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Isomorphic Labs Limited

United Kingdom

19 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services Isomorphic Labs is filed for, grouped by Nice class.

  • Pharmaceutical preparations.

  • Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development.

  • Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service [saas] services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services.

FAQ

About Isomorphic Labs

Who owns the trademark "Isomorphic Labs"?

The WIPO trademark "Isomorphic Labs" is owned by Isomorphic Labs Limited.

What is the status of "Isomorphic Labs"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Isomorphic Labs and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_4f5959cb-eec3-4e18-8187-2d3b7a442208
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_4f5959cb-eec3-4e18-8187-2d3b7a442208",
  "object": "trademark",
  "mark_text": "Isomorphic Labs",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2025-09-22",
  "nice_classes": [
    5,
    9,
    42
  ],
  "owners": [
    {
      "name": "ISOMORPHIC LABS LIMITED",
      "entity_id": "ent_019eb7c9-3699-730a-bc89-d456a3a4d4bf"
    }
  ]
}